Utama › Kanser Payudara › Florida › Tampa
Kajian klinikal Kanser Payudara di Tampa, FL
43 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar Tampa (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Mengambil pesertaFasa 2
- Moffitt Cancer Center, Tampa
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Moffitt Cancer Center, Tampa
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Mengambil pesertaFasa 1/2
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
Study of AVZO-021 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Avenzo Therapeutics Recruiting Site, Tampa
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Mengambil pesertaFasa 2
- Moffitt Cancer Center, Tampa
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
Mengambil pesertaFasa 2
- Moffitt Cancer Center, Tampa
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Mengambil pesertaFasa 3
- Clinical Trial Site, Tampa
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Mengambil pesertaFasa 1
- Moffitt, Tampa
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Mengambil pesertaFasa 1
- Moffitt, Tampa
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Mengambil pesertaFasa 3
- Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center, Tampa
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Mengambil pesertaFasa 3
- Moffitt Cancer Center, Tampa
Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery
Mengambil pesertaFasa 2
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Mengambil pesertaFasa 1/2
- Moffitt Cancer Center, Tampa
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Mengambil pesertaFasa 1/2
- Moffitt Cancer Center, Tampa
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Mengambil pesertaFasa 3
- Moffitt Cancer Center-McKinley Campus, Tampa
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Mengambil pesertaFasa 1
- Moffitt Cancer Center, Tampa
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Mengambil pesertaFasa 3
- Moffitt Cancer Center, Tampa
Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD
Mengambil pesertaFasa 2
- Moffitt Cancer Center, Tampa
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Moffitt Cancer Center, Tampa
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
Mengambil pesertaFasa 2
- Moffitt Cancer Center, Tampa
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Mengambil pesertaFasa 1/2
- Moffitt Cancer Center, Tampa
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
Mengambil pesertaFasa 1/2
- Moffitt Cancer Center, Tampa
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Mengambil pesertaFasa 1
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Tampa
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
Mengambil pesertaFasa 2
- Moffitt Cancer Center, Tampa
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
Mengambil pesertaFasa 3
- Moffitt Cancer Center, Tampa
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mengambil pesertaFasa 2
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
- Moffitt Cancer Center, Tampa
ILR to Prevent BRCL_MCC 23608
Mengambil peserta
- Tampa General Hospital, Tampa
- Moffitt Cancer Center, Tampa
- University of South Florida, Tampa
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Mengambil pesertaFasa 3
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
Mengambil pesertaFasa awal 1
- Moffitt Cancer Center, Tampa
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Mengambil pesertaKajian pemerhatian
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
Mengambil pesertaFasa 2
- Moffitt Cancer Center, Tampa
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
Mengambil pesertaFasa 1
- Moffitt Cancer Center, Tampa
The MIND-BC Study: MIND Diet for Breast Cancer Cognition
Mengambil peserta
- Moffitt Cancer Center, Tampa
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Mengambil pesertaKajian pemerhatian
- St. Joseph's Women's Hospital, Tampa
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
Mengambil pesertaFasa 1/2
- Moffitt Cancer Center, Tampa
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
Mengambil pesertaFasa 2
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Tampa
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Mengambil pesertaFasa 3
- Moffitt Cancer Center, Tampa
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #16, Tampa
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Mengambil pesertaKajian pemerhatian
- St. Joseph's Hospital - Baycare, Tampa
- University of South Florida, Tampa
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Mengambil pesertaFasa 2
- Moffitt Cancer Center, Tampa
Kajian Kanser Payudara di bandar lain
- New York City, NY136 kajian
- Houston, TX126 kajian
- Boston, MA112 kajian
- Nashville, TN81 kajian
- Los Angeles, CA73 kajian
- Edison, NJ68 kajian
- St. Louis, MO64 kajian
- Queens, NY64 kajian
- Durham, NC64 kajian
- Chicago, IL59 kajian
- Philadelphia, PA56 kajian
- Dallas, TX55 kajian
Kajian lain di Tampa
- Kanser Paru-paru Bukan Sel Kecil51 kajian
- Kanser (semua jenis)39 kajian
- Kanser Kolorektal34 kajian
- Leukemia Mieloid Akut29 kajian
- Kanser Metastatik29 kajian
- Kanser Paru-paru29 kajian
- Kanser Pankreas26 kajian
- Kanser Ovari21 kajian
- Melanoma19 kajian
- Sindrom Mielodisplastik19 kajian
- Kanser Prostat18 kajian
- Kegagalan Jantung18 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.